CVS Health Corp.
CVSLast close · Oct 16, 202692.36−0.22 (−0.24%)
Market cap$118.1B
Key indicators
Revenue415.1B+7.4% on a year earlier
193.9B
256.8B
268.7B
292.1B
322.5B
357.8B
372.8B
402.1B
415.1B
416.6B
429.6B
449.2B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 193.9B | 256.8B+32.4% | 268.7B+4.6% | 292.1B+8.7% | 322.5B+10.4% | 357.8B+10.9% | 372.8B+4.2% | 402.1B+7.8% | 415.1B+7.4% | 416.6B | 429.6B | 449.2B | |
| — | 32.4% | 4.6% | 8.7% | 10.4% | 10.9% | 4.2% | 7.8% | 7.4% | 3.6% | 3.1% | 4.5% | |
| -$0.57 | $5.08+991.2% | $5.46+7.5% | $5.95+9.0% | $3.14−47.2% | $6.47+106.1% | $3.66−43.4% | $1.39−62.0% | $3.79+5.9% | $8.02 | $8.52 | $9.70 | |
| Profitability | ||||||||||||
| 2.1% | 4.7%+2.6 pt | 5.2%+0.5 pt | 4.5%−0.7 pt | 2.4%−2.1 pt | 3.8%+1.4 pt | 2.3%−1.6 pt | 1.2%−1.1 pt | 2.0%−0.3 pt | · | · | · | |
| -0.3% | 2.6%+2.9 pt | 2.7%+0.1 pt | 2.7%+0.0 pt | 1.3%−1.4 pt | 2.3%+1.0 pt | 1.2%−1.1 pt | 0.4%−0.8 pt | 1.2%+0.0 pt | · | · | · | |
| -1.0% | 10.4%+11.4 pt | 10.3%−0.0 pt | 10.5%+0.2 pt | 5.8%−4.7 pt | 10.9%+5.1 pt | 6.1%−4.8 pt | 2.4%−3.8 pt | — | · | · | · | |
| Cash | ||||||||||||
| 6.8B | 10.4B+52.2% | 13.4B+29.2% | 15.7B+17.3% | 13.4B−14.6% | 10.4B−22.7% | 6.3B−39.1% | 7.8B+23.4% | 11.8B+146.0% | · | · | · | |
| 3.5% | 4.0%+0.5 pt | 5.0%+1.0 pt | 5.4%+0.4 pt | 4.2%−1.2 pt | 2.9%−1.3 pt | 1.7%−1.2 pt | 1.9%+0.2 pt | 2.8%+1.6 pt | · | · | · | |
| 2.0B | 2.6B+27.7% | 2.6B+0.8% | 2.6B+0.0% | 2.9B+10.7% | 3.1B+7.7% | 3.4B+7.7% | 3.4B+0.7% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 1.26x | 1.07x−0.19x | 0.93x−0.14x | 0.75x−0.18x | 0.74x−0.01x | 0.81x+0.07x | 0.88x+0.07x | 0.86x−0.02x | 0.77x−0.09x | · | · | · | |
| 1.04B | 1.30B+25.0% | 1.31B+0.7% | 1.33B+1.1% | 1.32B−0.5% | 1.29B−2.5% | 1.26B−2.2% | 1.27B+0.7% | 1.29B+1.3% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.